ChiCTR2500103459 版本V1.0 版本创建时间2025/05/29 15:04:54 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500103459 

最近更新日期:

Date of Last Refreshed on:

2025-05-29 15:04:47 

注册时间:

Date of Registration:

2025-05-29 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于代谢组学研究硬膜外分娩镇痛相关发热的机制

Public title:

Based on metabonomics to study the mechanism of intrapartum maternal fever during epidural labor analgesia

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于代谢组学研究硬膜外分娩镇痛相关发热的机制

Scientific title:

Based on metabonomics to study the mechanism of intrapartum maternal fever during epidural labor analgesia

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张敏玉 

研究负责人:

张敏玉 

Applicant:

Minyu Zhang 

Study leader:

Minyu Zhang 

申请注册联系人电话:

Applicant telephone:

+86 138 2069 2209

研究负责人电话:

Study leader's
telephone:

+86 138 2069 2209

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

beginner228@163.com

研究负责人电子邮件:

Study leader's E-mail:

beginner228@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

天津市南开区三马路156号

研究负责人通讯地址:

天津市南开区三马路156号

Applicant address:

No. 156, Sanma Road, Nankai District, Tianjin City

Study leader's address:

No. 156, Sanma Road, Nankai District, Tianjin City

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

天津市中心妇产科医院

Applicant's institution:

Tianjin Central Hospital of Gynecology and Obstetrics

研究负责人所在单位:

天津市中心妇产科医院

Affiliation of the Leader:

Tianjin Central Hospital of Gynecology and Obstetrics

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025KY062

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

天津市中心妇产科医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Tianjin Central Obstetrics and Gynecology Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2025-04-14 00:00:00

伦理委员会联系人:

陈蕾伊

Contact Name of the ethic committee:

Leiyi Chen

伦理委员会联系地址:

天津市中心妇产科医院

Contact Address of the ethic committee:

Tianjin Central Hospital of Gynecology and Obstetrics

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 22 5828 7942

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

天津市中心妇产科医院

Primary sponsor:

Tianjin Central Hospital of Gynecology and Obstetrics

研究实施负责(组长)单位地址:

天津市南开区三马路156号

Primary sponsor's address:

No. 156, Sanma Road, Nankai District, Tianjin City

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

天津

市(区县):

Country:

China

Province:

Tianjin

City:

单位(医院):

天津市中心妇产科医院

具体地址:

天津市南开区三马路156号

Institution
hospital:

Tianjin Central Hospital of Gynecology and Obstetrics

Address:

No. 156, Sanma Road, Nankai District, Tianjin City

经费或物资来源:

自筹

Source(s) of funding:

self-raised

研究疾病:

硬膜外分娩镇痛相关发热  

Target disease:

mechanism of intrapartum maternal fever

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

主要目的 探讨硬膜外分娩镇痛期间产妇发热发生的机制 次要目的 1)探讨产时发热的可能原因,鉴别椎管内分娩镇痛发热的影响因素及对产妇和新生儿结局的影响 2)探索分娩镇痛产时发热的预防及处理措施,包括镇痛药物的选择、浓度、持续时间,以及产程产后管理,优化产妇无痛分娩体验 3)探讨产妇发热对胎儿及新生儿的影响,为改善新生儿不良结局提供参考  

Objectives of Study:

Main purpose To explore the mechanism of parturient fever during epidural labor analgesia Secondary purpose 1) To explore the possible causes of fever during labor, identify the influencing factors of fever in intraspinal labor analgesia and its impact on the outcomes of parturients and neonates 2) Explore the prevention and treatment measures for fever during labor in labor analgesia, including the selection, concentration, duration of analgesic drugs, as well as postpartum management during labor, to optimize the painless delivery experience of parturients 3) To explore the effects of maternal fever on fetuses and newborns, and to provide references for improving adverse neonatal outcomes

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.妊娠足月单胎、年龄20-35岁并自愿选择硬膜外分娩镇痛; 2.分娩前一周无发热史,无高血压、糖尿病、心脑血管等其他合并症.

Inclusion criteria

1. Full-term singleton pregnancy, aged 20-35 years old, and voluntarily choosing epidural labor analgesia; 2. There was no history of fever one week before delivery, and no other complications such as hypertension, diabetes, cardiovascular and cerebrovascular diseases.

排除标准:

1. BMI>35kg/m^2或<20kg/m^2、产次>1次、非头位胎位、硬膜外麻醉禁忌及相关药物过敏; 2. 硬膜外镇痛前已发热或感染、胎膜早破、急产.

Exclusion criteria:

1. BMI>35kg/m^2 or <20kg/m^2, parity>1 times, non-cephalic fetal position, contraindications to epidural anesthesia and related drug allergies; 2. Fever or infection, premature rupture of membranes, and acute labor before epidural analgesia.

研究实施时间:

Study execute time:

From 2023-07-01 00:00:00 To 2026-02-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-06-01 00:00:00 To 2025-08-31 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

10

Group:

Control group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

观察组

样本量:

10

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

天津 

市(区县):

 

Country:

China

Province:

Tianjin

City:

单位(医院):

天津市中心妇产科医院 

单位级别:

三甲 

Institution
hospital:

Tianjin Central Hospital of Gynecology and Obstetrics

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

代谢组学检测分析

指标类型:

主要指标

Outcome:

Metabolomics detection and analysis

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 20 years
最大 Max age 40 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

none

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case record form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-05-29 15:04:47